These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18756021)

  • 1. Study on the nitric oxide generating effects from aristolochic acid in vitro.
    Xu Q; Ma C; Wang W; Fu X; Tang C; Hattori M
    Eur J Mass Spectrom (Chichester); 2008; 14(4):231-7. PubMed ID: 18756021
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dedı Ková A; Bárta F; Martínek V; Kotalík K; Dušková Š; Mráz J; Arlt VM; Stiborová M; Hodek P
    Chem Res Toxicol; 2020 Nov; 33(11):2804-2818. PubMed ID: 32894017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.
    Chan W; Zheng Y; Cai Z
    J Am Soc Mass Spectrom; 2007 Apr; 18(4):642-50. PubMed ID: 17208007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach for the sensitive determination of DNA adduct of aristolochic acid II by using high-performance liquid chromatography with fluorescence detection.
    Chan W; Poon WT; Chan YW; Wan KY; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):848-52. PubMed ID: 19249256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of aristolochic acids I and II.
    Krumbiegel G; Hallensleben J; Mennicke WH; Rittmann N; Roth HJ
    Xenobiotica; 1987 Aug; 17(8):981-91. PubMed ID: 3673113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cytotoxic effects of denitroaristolochic acid II and aristolochic acids on renal epithelial cells.
    Liu Q; Wang Q; Yang X; Shen X; Zhang B
    Toxicol Lett; 2009 Jan; 184(1):5-12. PubMed ID: 19026731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved preparation and identification of aristolochic acid-DNA adducts by solid-phase extraction with liquid chromatography-tandem mass spectrometry.
    Gao H; Guo F; Feng F; Yin J; Song M; Wang H
    J Environ Sci (China); 2009; 21(12):1769-76. PubMed ID: 20131611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
    Broschard TH; Wiessler M; Schmeiser HH
    Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid I metabolism in the isolated perfused rat kidney.
    Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR
    Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.
    Pfau W; Schmeiser HH; Wiessler M
    Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Spectrometric and Spectrofluorometric Studies of the Interaction of Aristolochic Acids with Proteins.
    Li W; Hu Q; Chan W
    Sci Rep; 2015 Oct; 5():15192. PubMed ID: 26471474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for in vitro metabolites of kakkalide and irisolidone in human and rat intestinal bacteria by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Zhang G; Gong T; Kano Y; Yuan D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():117-24. PubMed ID: 24412694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted LC-MS-based metabonomics revealed that aristolochic acid I induces testicular toxicity by inhibiting amino acids metabolism, glucose metabolism, β-oxidation of fatty acids and the TCA cycle in male mice.
    Cui Y; Han J; Ren J; Chen H; Xu B; Song N; Li H; Liang A; Shen G
    Toxicol Appl Pharmacol; 2019 Jun; 373():26-38. PubMed ID: 31009690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF as a method for biomarker discovery in the urine of aristolochic-acid-treated mice.
    Huang F; Clifton J; Yang X; Rosenquist T; Hixson D; Kovac S; Josic D
    Electrophoresis; 2009 Apr; 30(7):1168-74. PubMed ID: 19294690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.